Search
01/03/2022
Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists
de Santiago, ER, Aldehuelo, RS, Pons, FR, Escaja, CR, Fernandez-Esparrach, G, Canete-Ruiz, A, Aracil, CF, Perez-Corte, D, Leon, RR, Marcos-Prieto, HM, Delgado-Guillena, PG, Garcia-Rodriguez, A, Guarner-Argente, C, Muriel, A, de la Fuente-Briongos, E, de Paredes, AGG, Parejo-Carbonell, S, Tellez, L, Senosiain-Lalastra, C, Burgos-Santamaria, D, Aicart-Ramos, M, Munoz, BM, Penas-Garcia, B, Pagano, G, Urquiza, GC, Ferreruela, MU, de Jorge-Turrion, MA, Barreiro-Alonso, E, Fraile-Lopez, M, Gomez-Outomuro, A, Altamirano, MI, Esteban, MN, Ruiz-Andreu, M, Arribas-Anta, J, de Frutos, D, Herreros-de-Tejada, A, Arias-Rivera, ML, Roldan-Fernandez, M, Martin, AFM, Zamora, J, Vazquez-Sequeiros, E, Albillos, A. Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists. Clinical Gastroenterology and Hepatology. 2022; 20(3)DOI:10.1016/j.cgh.2020.11.037. PMID:33279783. IF:12.600(Q1/1D).
01/03/2022
Epidemiology of Echovirus 30 Infections Detected in a University Hospital in Catalonia, Spain, in 1995-2020
del Cuerpo, M, de Audicana, JG, Fernandez-Garcia, MD, Marin, P, Esteban, M, Espanol, M, Cabrerizo, M, Rabella, N. Epidemiology of Echovirus 30 Infections Detected in a University Hospital in Catalonia, Spain, in 1995-2020. Microorganisms. 2022; 10(3)DOI:10.3390/microorganisms10030592. PMID:35336167. IF:4.500(Q2/4D).
01/03/2022
Tetracycline resistance transmission in Campylobacter is promoted at temperatures resembling the avian reservoir (vol 244, 108652, 2020)
Cuevas-Ferrando, E, Guirado, P, Miro, E, Iglesias-Torrens, Y, Navarro, F, Alioto, TS, Gomez-Garrido, J, Madrid, C, Balsalobre, C. Tetracycline resistance transmission in Campylobacter is promoted at temperatures resembling the avian reservoir (vol 244, 108652, 2020). VETERINARY MICROBIOLOGY. 2022; 266DOI:10.1016/j.vetmic.2022.109368. PMID:35216838. IF:3.300(Q1/1D).
01/03/2022
Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists
Alvarado, PM, de Oro, JJD, Espinar, MA, Perez, EA, Perez, NB, Carmona, L, Burgos, EC, Poch, TC, Aguilera, AC, Mendieta, ED, Alarcon, PE, Casares, EG, Perez, SH, Lopez, BM, Morillo, MM, Soria, LM, Pastor, CM, Martinez-Losa, MM, Fernandez, AP, Busquets, MP, Garcia, JR, Sanz, DR, Lizarzaburu, MS, Santo Panero, P, Alierta, ES, Roc, MV, Macias, HC. Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists. RHEUMATOLOGY INTERNATIONAL. 2022; 42(3)DOI:10.1007/s00296-020-04733-y. PMID:33146762. IF:4.000(Q2/5D).
01/03/2022
Effect of CPAP treatment on BP in resistant hypertensive patients according to the BP dipping pattern and the presence of nocturnal hypertension
Sapina-Beltran, E, Benitez, ID, Torres, G, Fortuna-Gutierrez, AM, Marquez, PP, Masa, JF, Drager, LF, Cabrini, M, Felez, M, Vazquez, S, Abad, J, Lee, C, Garcia-Rio, F, Casitas, R, Mediano, O, Peralta, SR, Martinez, D, Sanchez-de-la-Torre, M, Barbe, F, Dalmases, M. Effect of CPAP treatment on BP in resistant hypertensive patients according to the BP dipping pattern and the presence of nocturnal hypertension. HYPERTENSION RESEARCH. 2022; 45(3)DOI:10.1038/s41440-021-00762-7. PMID:34952953. IF:5.400(Q2/3D).
01/03/2022
Anxiety and body mass index affect asthma control: data from a prospective Spanish cohort
Baptista-Serna L., Rodrigo-Muñoz J.M., Mínguez P., Valverde-Monge M., Arismendi E., Barranco P., Barroso B., Bobolea I., Cañas J.A., Cárdaba B., Cruz M.J., Curto E., Domínguez-Ortega J., García-Latorre R., González-Barcala F.J., Martínez-Rivera C., Mullol J., Muñoz X., Olaguibel J.M., Picado C., Plaza V., Quirce S., Rial M.J., Sastre B., Soto L., Valero A., del Pozo V., Sastre J.. Anxiety and body mass index affect asthma control: data from a prospective Spanish cohort. Journal of Allergy and Clinical Immunology-In Practice. 2022; 10(3)DOI:10.1016/j.jaip.2021.10.013. PMID:34673289. IF:9.400(Q1/2D).
01/03/2022
Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
Agusti, A, De Stefano, G, Levi, A, Munoz, X, Romero-Mesones, C, Sibila, O, Lopez-Giraldo, A, Moral, VP, Curto, E, Echazarreta, AL, Marquez, SE, Pascual-Guardia, S, Santos, S, Marin, A, Valdes, L, Saldarini, F, Salgado, C, Casanovas, G, Varea, S, Rios, J, Faner, R. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial. EUROPEAN RESPIRATORY JOURNAL. 2022; 59(3)DOI:10.1183/13993003.03036-2021. PMID:35144989. IF:24.300(Q1/1D).
01/03/2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
Podzamczer, D, Mican, R, Tiraboschi, J, Portilla, J, Domingo, P, Llibre, JM, Ribera, E, Vivancos, MJ, Morano, L, Masia, M, Gomez, C, Fanjul, F, Payeras, A, Inciarte, A, Estrada, V, Rivero, A, Castro, A, Bernal, E, Vinuesa, D, Knobel, H, Troya, J, Macias, J, Montero, M, Sanz, J, Navarro-Alcaraz, A, Caicedo, A, Fernandez, G, Martinez, E, Moreno, S. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57). Open Forum Infectious Diseases. 2022; 9(3)DOI:10.1093/ofid/ofab595. PMID:35237700. IF:4.200(Q2/4D).
01/03/2022
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines
Garcia-Alfonso, P, Saiz-Rodriguez, M, Mondejar, R, Salazar, J, Paez, D, Borobia, AM, Safont, MJ, Garcia-Garcia, I, Colomer, R, Garcia-Gonzalez, X, Herrero, MJ, Lopez-Fernandez, LA, Abad-Santos, F. Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines. Clinical & Translational Oncology. 2022; 24(3)DOI:10.1007/s12094-021-02708-4. PMID:34773566. IF:3.400(Q3/6D).
01/03/2022
PIVOT-12: a Phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence
Eggermont, AMM, Ascierto, PA, Khushalani, NI, Schadendorf, D, Boland, G, Weber, J, Lewis, KD, Johnson, D, Rivalland, G, Khattak, A, Majem, M, Gogas, H, Long, GV, Currie, SL, Chien, D, Tagliaferri, MA, Carlino, MS, Diab, A. PIVOT-12: a Phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence. Future Oncology. 2022; 18(8)DOI:10.2217/fon-2021-1286. PMID:35073733. IF:3.300(Q3/6D).
01/03/2022
Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome
Sanchez, A, Roos, VH, Navarro, M, Pineda, M, Caballol, B, Moreno, L, Carballal, S, Rodriguez-Alonso, L, Cajal, TRY, Llort, G, Pinol, V, Lopez-Fernandez, A, Salces, I, Pico, MD, Rivas, L, Bujanda, L, Garzon, M, Pizarro, A, de Castro, EM, Lopez-Arias, MJ, Poves, C, Garau, C, Rodriguez-Alcalde, D, Herraiz, M, Alvarez-Urrutia, C, Dacal, A, Carrillo-Palau, M, Cid, L, Ponce, M, Barreiro-Alonso, E, Saperas, E, Aguirre, E, Romero, C, Bastiaansen, B, Gonzalez-Acosta, M, Morales-Romero, B, Ocana, T, Rivero-Sanchez, L, Jung, G, Bessa, X, Cubiella, J, Jover, R, Rodriguez-Moranta, F, Balmana, J, Brunet, J, Castells, A, Dekker, E, Capella, G, Serra-Burriel, M, Moreira, L, Pellise, M, Balaguer, F. Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome. Clinical Gastroenterology and Hepatology. 2022; 20(3)DOI:10.1016/j.cgh.2020.11.002. PMID:33157315. IF:12.600(Q1/1D).
01/03/2022
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
Wu, YL, John, T, Grohe, C, Majem, M, Goldman, JW, Kim, SW, Kato, T, Laktionov, K, Vu, HV, Wang, ZJ, Lu, S, Lee, KY, Akewanlop, C, Yu, CJ, de Marinis, F, Bonanno, L, Domine, M, Shepherd, FA, Zeng, LM, Atasoy, A, Herbst, RS, Tsuboi, M. Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC. Journal of Thoracic Oncology. 2022; 17(3)DOI:10.1016/j.jtho.2021.10.014. PMID:34740861. IF:20.400(Q1/1D).
01/03/2022
The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies
Sanchez, JM, Carratala, JV, Serna, N, Unzueta, U, Nolan, V, Sanchez-Chardi, A, Volta-Duran, E, Lopez-Laguna, H, Ferrer-Miralles, N, Villaverde, A, Vazquez, E. The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies. Pharmaceutics. 2022; 14(3)DOI:10.3390/pharmaceutics14030602. PMID:35335976. IF:5.400(Q1/2D).
01/03/2022
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
Hernandez-Boluda, JC, Pereira, A, Zinger, N, Gras, L, Martino, R, Paneesha, S, Finke, J, Chinea, A, Rambaldi, A, Robin, M, Saccardi, R, Natale, A, Snowden, JA, Tsirigotis, P, Vallejo, C, Wulf, G, Xicoy, B, Russo, D, Maertens, J, Daguindau, E, Lenhoff, S, Hayden, P, Czerw, T, McLornan, DP, Yakoub-Agha, I. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT. BONE MARROW TRANSPLANTATION. 2022; 57(3)DOI:10.1038/s41409-021-01553-x. PMID:35066569. IF:4.800(Q1/2D).
01/03/2022
Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery
Serna, N, Pallares, V, Unzueta, U, Garcia-Leon, A, Volta-Duran, E, Sanchez-Chardi, A, Parlade, E, Rueda, A, Casanova, I, Falgas, A, Alba-Castellon, L, Sierra, J, Villaverde, A, Vazquez, E, Mangues, R. Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery. JOURNAL OF CONTROLLED RELEASE. 2022; 343DOI:10.1016/j.jconrel.2022.01.017. PMID:35051493. IF:10.800(Q1/1D).
01/03/2022
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients
Ramos-Campoy, S, Puiggros, A, Bea, S, Bougeon, S, Larrayoz, MJ, Costa, D, Parker, H, Rigolin, GM, Ortega, M, Blanco, ML, Collado, R, Salgado, R, Baumann, T, Gimeno, E, Moreno, C, Bosch, F, Calvo, X, Calasanz, MJ, Cuneo, A, Strefford, JC, Nguyen-Khac, F, Oscier, D, Haferlach, C, Schoumans, J, Espinet, B. Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients. HAEMATOLOGICA. 2022; 107(3)DOI:10.3324/haematol.2020.274456. PMID:33691382. IF:10.100(Q1/2D).
01/03/2022
Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke The CHOICE Randomized Clinical Trial
Renu, A, Millan, M, San Roman, L, Blasco, J, Marti-Fabregas, J, Terceno, M, Amaro, S, Serena, J, Urra, X, Laredo, C, Barranco, R, Camps-Renom, P, Zarco, F, Oleaga, L, Cardona, P, Castano, C, Macho, J, Cuadrado-Godia, E, Vivas, E, Lopez-Rueda, A, Guimaraens, L, Ramos-Pachon, A, Roquer, J, Muchada, M, Tomasello, A, Davalos, A, Torres, F, Chamorro, A. Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke The CHOICE Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2022; 327(9)DOI:10.1001/jama.2022.1645. PMID:35143603. IF:120.700(Q1/1D).
01/03/2022
Predictors of Functional Outcome After Thrombectomy in Patients With Prestroke Disability in Clinical Practice
Millán M, Ramos-Pachón A, Dorado L, Bustamante A, Hernández-Pérez M, Rodríguez-Esparragoza L, Gomis M, Remollo S, Castaño C, Werner M, Wenger D, Rubio S, Domínguez-Lizarbe M, Terceño M, Paipa AJ, Rodríguez-Vázquez A, Boned S, Camps-Renom P, Cánovas D, Giralt E, López-Cancio E, Dávalos A, Ros-Roig J, Pérez de la Ossa N. Predictors of Functional Outcome After Thrombectomy in Patients With Prestroke Disability in Clinical Practice. STROKE. 2022; 53(3)DOI:10.1161/STROKEAHA.121.034960. PMID:34702065. IF:8.300(Q1/1D).
01/03/2022
International stroke genetics consortium recommendations for studies of genetics of stroke outcome and recovery
Lindgren, AG, Braun, RG, Majersik, JJ, Clatworthy, P, Mainali, S, Derdeyn, CP, Maguire, J, Jern, C, Rosand, J, Cole, JW, Lee, JM, Khatri, P, Nyquist, P, Debette, S, Wei, LK, Rundek, T, Leifer, D, Thijs, V, Lemmens, R, Heitsch, L, Prasad, K, Conde, JJ, Dichgans, M, Rost, NS, Cramer, SC, Bernhardt, J, Worrall, BB, Fernandez-Cadenas, I. International stroke genetics consortium recommendations for studies of genetics of stroke outcome and recovery. International Journal of Stroke. 2022; 17(3)DOI:10.1177/17474930211007288. PMID:33739214. IF:6.700(Q1/2D).
25/02/2022
Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study
Aapkes, SE, Bernts, LHP, van den Berg, AP, van den Berg, M, Blokzijl, H, Cantineau, AEP, van Gastel, MDA, de Haas, RJ, Kappert, P, Muller, RU, Nevens, F, Torra, R, Visser, A, Drenth, JPH, Gansevoort, RT. Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study. BMC GASTROENTEROLOGY. 2022; 22(1)DOI:10.1186/s12876-022-02142-y. PMID:35216547. IF:2.400(Q4/9D).